Memantine

Hot Sale Professional Pharmaceutical Intermediate Memantine CAS 19982-08-2

 

  • Ime izdelka:

    Memantine

  • Ocena:

    Farmacevtska kakovost

  • Lastnosti:

    Bel prah

  • Pakiranje:

    25 kg/boben

  • MOQ:

    1 ton

  • Shranjevanje:Hladno suho mesto
  • Rok trajanja:2 leti


Podrobnosti

Oznake

Opis izdelka

 

Memantine hydrochloride is a raw material. It should be prescribed by experienced doctors in the diagnosis and treatment of Alzheimer's dementia and guided by patients. Treatment can only begin when there are caregivers around the patient who regularly supervise the patient's medication. Dementia should be diagnosed in accordance with current diagnostic criteria and guidelines.

Memantine is a medication used to treat moderate-to-severe Alzheimer's disease. It is less preferred than acetylcholinesterase inhibitors such as donepezil. Treatment should only be continued if beneficial effects are seen. It is taken by mouth.
Memantine was approved for medical use in the United States in 2003.
 It is available as a generic medication. In 2017, it was the 149th most commonly prescribed medication in the United States, with more than four million prescriptions

Prikaz izdelka

 

Lastnosti

 

Memantine is clinically used for the treatment of moderate to severe senile dementia and parkinsonism syndrome. It is a new type of anti-senile dementia drug and can be used for the treatment of moderate to severe senile dementia.

Aplikacija

 

Memantine is used to treat moderate-to-severe Alzheimer's disease, especially for people who are intolerant of or have a contraindication to AChE (acetylcholinesterase) inhibitors.One guideline recommends memantine or an AChE inhibitor be considered in people in the early-to-mid stage of dementia.

Memantine has been associated with a modest improvement; with small positive effects on cognition, mood, behavior, and the ability to perform daily activities in moderate-to-severe Alzheimer's disease. There does not appear to be any benefit in mild disease.

Memantine when added to donepezil in those with moderate-to-severe dementia resulted in "limited improvements" in a 2017 review. The UK National Institute of Clinical Excellence (NICE) issued guidance in 2018 recommending consideration of the combination of memantine with donepezil in those with moderate-to-severe dementia. Effects in autism are unclear. Recent scientific journal reports are showing guarded promise with severe obsessive compulsive disorder.

 

Prednosti

 

Imamo veliko visokokakovostnih tovarn z globokim sodelovanjem, ki vam lahko zagotovijo visoko kakovostne izdelke in konkurenčne cene. Prav tako lahko nudimo popuste za nakupe v razsutem stanju. Sodelujemo s številnimi profesionalnimi špediterskimi podjetji, lahko varno in gladko dostavimo izdelke v vaše roke. Čas dostave je približno 3-20 dni po potrditvi plačila.

Specifikacija

 

Postavka

Requirements

Test Results

appearance

White or almost white crystalline powder 

White crystalline powder 

Identifikacija

IR 

Comply 

Related substance 

1-methyladamantane ≤0.3%

1,3,5 -trimethyladamantane ≤0.3%

Unknow impuritiy     ≤0.1%

Total impurity ≤0.5%

0.13%

0.14%

<0.1%

<0.4%

Ostanek pri žarenju 

≤0.1% 

0.06%

Heavy matal 

≤10ppm 

<10ppm 

Izguba pri sušenju 

≤0,5 %

0.29%

Esej

98.5-101.0%

99.13%

Residual

Solvents

Ethyl Acetat: ≤0.5%

Ethanol: ≤0.5%

0.08%

0.12%

PH

4.5-5.5 

5.3

Microbial Limits

Max 5*102 aerobes and fungl per 1g 

E. Coli: Negative Salmonella: Negative

 

Pass 

Size of distributed particles 

Pass 100μ m

Ustreza

Zaključek

Meet the requirements 

 

Poznavanje izdelka:

 

Memantine is a medication used to treat moderate-to-severe Alzheimer's disease. It is less preferred than acetylcholinesterase inhibitors such as donepezil. Treatment should only be continued if beneficial effects are seen. It is taken by mouth.
Memantine was approved for medical use in the United States in 2003.
 It is available as a generic medication. In 2017, it was the 149th most commonly prescribed medication in the United States, with more than four million prescriptions

Memantine HCl is the HCl form of Memantine. Memantine is a well- known neuroprotective drug used for the treatment of Alzheimer's disease. It is believed to be the first neuroprotective drug that has achieve clinical approval by US FDA as well as European.
The development of Alzheimer's disease involves the misfolded mutant proteins such as β-amyloid peptide (Aβ, particularly Aβ1−42). These misfolded mutant protein can increase the NMDA response and further cause severe excitotoxicity.
Memantine suppresses this process through acting as the antagonist of the N-methyl-d- aspartate-sensitive glutamate receptor (NMDARs).
Memantine is also under investigation as a potential treatment for other kind of neurodegenerative disorders such as HIV-associated dementia, neuropathic pain, glaucoma, depression, Huntington's disease, ALS and movement disorders, among other. 

 

Dostava in plačilo

 

 

 

pogosta vprašanja

 

1. Ali ste tovarna ali trgovska družba?
Smo podjetje, ki povezuje industrijo in trgovino ter nudi storitve na enem mestu. OEM je lahko sprejet.

2. Ali nudite vzorce? Je brezplačno ali dodatno?
Brezplačni vzorci. Tovornino za vzorec morate plačati sami.

3. Ali imate kakšne certifikate v zvezi s kontrolo kakovosti?
Certifikat ISO 9001:2008 za zagotavljanje kakovosti.

4. Kaj naj zagotovim, da dobim ponudbo?
Prosimo, obvestite nas o vrsti izdelka, ki ga potrebujete, količini naročila, naslovu in posebnih zahtevah. Ponudba bo pravočasno pripravljena za vašo referenco.

5. Kakšen način plačila vam je ljubši? Kakšni pogoji so sprejeti?
Sprejeti pogoji dostave: FOB, CFR, CIF, EXW;
Valuta sprejetega plačila: USD;
Sprejeta vrsta plačila: T/T, Western Union; Paypal, Trade Assurance.
Govorni jezik: angleščina.

 

Če vas zanimajo naši izdelki, lahko svoje podatke pustite tukaj in v kratkem vas bomo kontaktirali.


Tukaj napišite svoje sporočilo in nam ga pošljite